Helicobacter suis has a greater tendency to induce gastric mucosa-associated lymphoid tissue lymphoma compared with other Helicobacter species in humans and animals. Saccharomyces boulardii has been established as an adjunct to H. pylori eradication treatment, but the effect of S. boulardii administration alone on Helicobacter infection remains unclear. Here, we found that S. boulardii administration effectively decreased the bacterial load of H. suis and inhibited the formation of lymphoid follicles in the stomach post-infection. The levels of H. suis-specific immunoglobulin A (IgA) and secretory IgA in the gastric juice and small intestinal secretions and the production of mouse β-defensin-3 in the small intestinal secretions were significantly increased by S. boulardii administration at 12 weeks after H. suis infection. In addition, feeding with S. boulardii inhibited the expression of inflammatory cytokines and lymphoid follicle formation-related factors after H. suis infection. These results suggested that S. boulardii may be useful for the prevention and treatment of Helicobacter infection-related diseases in humans.
INTRODUCTION
Helicobacter suis, which was originally named Helicobacter heilmannii type 1 based on the sequences of its 16S rRNA and urease genes (O'Rourke et al. 2004) , primarily colonizes the gastric mucosa of pigs, causing gastritis and ulceration of the nonglandular part of the stomach (Grasso et al. 1996; Park et al. 2000; Hellemans et al. 2007) . Helicobacter suis is also the most frequent non-H. pylori Helicobacter species in humans and is associated with gastritis (Debongnie, Donnay and Mairesse 1995; Okiyama et al. 2005) , peptic ulcer (Debongnie et al. 1998 ) and gastric carcinoma (Morgner et al. 1995; Duttala et al. 2008) . Furthermore, a clinical study reported that primary gastric mucosa-associated lymphoid tissue (MALT) lymphoma occurred more frequently in H. heilmannii-infected patients (1.47%) than in H. pylori-infected patients (0.66%) (Morgner et al. 2000) . Compared with H. pylori, H. suis is a fastidious, larger spiral-shaped bacterium that has not been reliably cultured in vitro. However, H. suis derived from pig stomachs can stably colonize in the stomachs of mice and induce the formation of gastric lymphoid follicles consisting of B cells and CD4 + T cells (Yamamoto et al. 2011) , which is tertiary lymphoid tissue that provides a histological background that can ultimately progress to gastric MALT lymphoma after long-term antigenic stimulation (Morgner et al. 2000; Aloisi and Pujol-Borrell 2006; Carragher, Rangel-Moreno and Randall 2008) . Moreover, H. suis obtained from Cynomolgus monkeys can induce gastric MALT lymphoma-like lesions in almost 100% of infected C57BL/6 mice after a 6-month period (Nakamura et al. 2007) , indicating that H. suis-infected mice are useful animal models for studying the pathogenesis of gastric MALT lymphoma. Probiotics are live bacteria that confer a health benefit to the host. Several studies have provided evidence that probiotics may also compete directly with H. pylori, either through interference with other pathogen colonization or by the production of antimicrobial molecules (Dore, Goni and Di Mario 2015) . Recently, reports claim that certain probiotic strains, such as Saccharomyces boulardii, which is a facultative anaerobic fungus that is resistant to gastric acid, pepsin and antibiotics, can exhibit inhibitory activity against H. pylori (Sakarya and Gunay 2013), reduce the occurrence of side effects due to antibiotic therapy and, consequently, increase the H. pylori eradication rate (Szajewska, Horvath and Kotodziej 2015) . However, the effect of S. boulardii administration alone on the colonization of Helicobacter in the stomach and the formation of gastric MALT post-infection remains unclear.
In this study, S. boulardii was fed to mice with or without H. suis infection to determine the effect of this probiotic administration on the bacterial load of H. suis in the stomach and the formation of gastric lymphoid follicles induced by H. suis infection. In addition, the production of mucosal IgA and mouse β-defensin-3 (mBD-3) in the gastrointestinal (GI) tract and the expression of inflammatory cytokines and lymphoid follicle formation-related factors after H. suis infection with or without S. boulardii administration were also estimated.
MATERIALS AND METHODS

Mice
All procedures and animal experiments were approved by the Animal Care and Use Committee of Qingdao University based on current ethical standards. C57BL/6 mice (wild-type mice) were purchased from Peng Yue Experimental Animal Breeding Ltd. (Jinan, China). All mice were specific-pathogen-free and bred under standard laboratory conditions.
Helicobacter suis infection
Currently, H. suis cannot be reliably cultivated in vitro in our laboratory. Therefore, H. suis obtained from pig stomachs with natural infection was maintained in the stomachs of C57BL/6 WT mice as donor mice. Twenty C57BL/6 female (8 weeks old) mice were randomly divided into four groups of five mice each: normal control (NC) group, H. suis-infected (HS) group, Saccharomyces boulardii feeding (SB) group, and H. suis infected and S. boulardii fed (HS+SB) group. The mice in the HS and HS+SB groups were infected with H. suis by orally administering the same amount of gastric mucosal homogenate from donor mice that has been confirmed to contain only H. suis but no other Helicobacter species (H. pylori, H. rodentium, H. typhlonium, H. hepaticus and H. muridarum) in the stomach using PCR analysis with specific 16s rRNA primers according to a previous report (Yamamoto et al. 2011) . The mice in the NC and SB groups received an equal volume of gastric mucosal homogenate from non-infected WT mice.
Saccharomyces boulardii administration
Saccharomyces boulardii (SB), which was obtained from Biocodex (Gentilly, France), was suspended in sterile distilled water (DW) as drinking water (3×10 8 CFU per ml) (Qamar et al. 2001 ) and fed to the mice of the SB and HS+SB groups from the time of H. suis infection until the time of sacrifice. The mice in the NC and HS groups were fed DW and served as controls.
Histological examination
At 12 weeks after H. suis infection, the mice were sacrificed by cervical dislocation under anesthesia. Their stomachs were then resected, opened at the outer curvature and sliced longitudinally from the esophagus to the duodenum. Half of the stomach was embedded in paraffin wax, and the other half of the stomach was used to extract RNA. The number and major axis size of clearly identified gastric lymphoid follicles in three specimens from each mouse were determined using a microscope in a blinded manner. The major axis of lymphoid follicles was measured using the scale bar of the microscope. A fraction of <10 μm was rounded down (Nobutani et al. 2010 ).
Enzyme-linked immunosorbent assay
The original levels of H. suis-specific immunoglobulin (IgA), secretory IgA (sIgA) and mBD-3 in the serum, gastric juice and small intestinal secretions were assessed according to the method used in previous reports (Rodrigues et al. 2000; Qamar et al. 2001; Yamamoto et al. 2014) . Mice were deprived of food for 24 h and water for 2 h. Under anesthesia, the mouse stomach was ligated at cardia and pylorus. Then the whole stomach was rinsed with 1 ml sterile PBS using syringe and all the fluids were collected to centrifuge at 16 000 x g for 10 min at 4
• C before the resultant supernatant was obtained. The serum was separated from the blood by centrifugation at 15 000 x g for 10 min at 4 • C, and the obtained gastric juice was centrifuged at 16 000 x g for 10 min at 4
• C before the resultant supernatant was collected. The small intestine from the pylorus to the cecum was removed. The contents were withdrawn, weighed and diluted in PBS at a ratio of 500 mg of intestinal contents per 2 ml of PBS. After centrifugation at 16 000 x g for 10 min at 4
• C, the supernatant fluid was collected. The original levels of sIgA and mBD-3 in the serum, gastric juice and small intestinal secretions were detected using a mouse sIgA enzyme-linked immunosorbent assay (ELISA) kit (USCN Life Science Inc., Wuhan, China) and a mouse β-defensin ELISA kit (Glory Science Co., Ltd, Hangzhou, China) according to the manufacturer's protocol. For H. suis-specific IgA level detection, 96-well plates were coated overnight at 4
• C with 100 μl of a bicarbonate solution (pH 9.6) containing 100 μg/ml H. pylori lysate, followed by blocking by the addition of 1.5% (wt/vol) BSA in PBS for 1 h at 37
• C. The serum, gastric juice and small intestinal secretions were diluted at 1:200, 1:10 and 1:20, respectively, and were added to the plates, followed by the addition of 100 μl of HRP-conjugated goat anti-mouse IgA antibody (Southern Biotech, Birmingham, AL) diluted at 1:5000 in PBST The quantitative values were normalized to the mouse β-actin expression level in each sample. Data are representative of at least three independent experiments and shown as the mean ± SD (n = 5). * Significant difference (P < 0.05); * * significant difference (P < 0.01); ND, not detected.
with 0.05% Tween 20 containing 0.2% BSA. The bound antibody was detected by the addition of o-phenylenediamine substrate, and measurement of absorbance at 490 nm was performed.
Quantitative real-time PCR
The mucosal and submucosal layers of the stomach and 5 cm of the small intestine from the terminal ileum were homogenized with 1 ml of TRIZOL reagent (Invitrogen, Carlsbad, CA). RNA was extracted from the homogenates according to the manufacturer's instructions before being subjected to a reverse transcription reaction using cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) according to the manufacturer's protocols. Quantitative real-time PCR was performed using Power SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7500 Real Time PCR system (Applied Biosystems) according to the manufacturer's instructions. The following specific primer pairs were used for the real-time PCR: H. suis-specific 16S rRNA gene: 5 -AGACAAAGCCTCCCAACAAC-3 and 5 -ATCACTGAC GCTGATTGCAC-3 ; mBD-3: 5 -GCTTC AGTCATGAGGATCCATTACCTTC-3 and 5 -CG GGATCTTGGTCT TCTCTA-3 ; CXC chemokine ligand 15 (CXCL15): 5 -CGGCAA TGAAGCTTCTGTAT-3 and 5 -CCT TGAAACTCTTTGCCTCA-3 ; TNF-α: 5 -CATCTTCTCAAAATTCGAGTGACAA-3 and 5 -TGGGA GTAGACAAGGTACAACCC-3 ; suppressor of cytokine signaling (SOCS)-1: 5 -ACTTCTGGCTGCTCA-3 and 5 -CCCAGAC ACAAGCTGCTACA-3 ; SOCS-2:5 -TGT GCAAGGATAAACGGACA-3 and 5 -AATGGCGAGTCGACAGAAAT-3 ; SOCS-3: 5 -AT TCACCC AGGTGGCTACAG-3 and 5 -CGGACCTACTGACCGAGAGA-3 ; IFN-γ : 5 -GC GTATTGAATCACACCTG-3 and 5 -TGAGCTCATT GAATGCTTGG-3 ; CXCL13: 5 -CAT AGATCGGATTCAAGTTACG CC-3 and 5 -TCTTGGTCCAGATCACAACTTCA-3 ; CC chemokine ligand 2 (CCL2): 5 -GCTGGAGCATCCACGTGTT-3 and 5 -ATCTTGCTGGTG AATGAGTAGCA-3 ; and β-actin: 5 -AAGGCCAACCGTGAAAAGAT-3 and 5 -GTGGT ACGACCAGAGGC ATAC-3 . To allow comparisons of relative gene expression levels, the comparative CT ( CT) method was used, and measurements were normalized using β-actin cDNA as an endogenous control.
Statistical analysis
All results are shown as means ± SD. Student's t-test was used for comparisons between two groups, and non-repeated measures analysis of variance was used for comparisons between three or more groups to analyze statistical significance. A level of probability of 0.05 or 0.01 was regarded as the significance criterion.
RESULTS
The formation of gastric lymphoid follicles was inhibited and the bacterial load in the stomachs of mice was decreased by Saccharomyces boulardii administration at 12 weeks after Helicobacter suis infection Twelve weeks after H. suis infection, the formation of gastric lymphoid follicles and the mean number and mean major axis size of follicles in the HS+SB group (with S. boulardii administration) were significantly decreased compared with the HS group (without S. boulardii administration) (Fig. 1A-C) . Interestingly, the H. suis-specific 16S rRNA gene was also detected in the small intestine even though the bacterial load was much lower than that in the stomach. The number of H. suis bacteria in the stomach and small intestine in the HS+SB group was significantly lower than that in the HS group (Fig. 1D) . These results suggested that S. boulardii administration could inhibit the formation of gastric lymphoid follicles induced by H. suis infection and decrease the bacterial load of H. suis in the stomach and small intestine.
The levels of Helicobacter suis-specific IgA and sIgA in the gastric juice and small intestinal secretions were significantly increased by Saccharomyces boulardii administration at 12 weeks after Helicobacter suis infection
IgA is an important functional component of the adaptive immune system, specifically at mucosal sites such as in the GI tract. Helicobacter pylori infection stimulates strong local inflammatory and specific IgA antibody production. Lower IgA levels were associated with higher bacterial density, suggesting a protective role of specific IgA against H. pylori infection (Srivastava et al. 2013) . sIgA is the predominant immunoglobulin at mucosal surfaces and represents the most efficient and effective immune barrier against pathogenic microorganisms, including H. pylori (Srivastava et al. 2013) . In this study, the levels of H. suisspecific IgA and sIgA in the serum, gastric juice and small intestinal secretions were detected by ELISA. As a result, H. suis infection induced the production of Helicobacter-specific IgA and sIgA in the serum, gastric juice and small intestinal secretions. Furthermore, S. boulardii administration increased the H. suisspecific IgA level in the serum, gastric juice and small intestinal secretions of the HS+SB group at 12 weeks after H. suis infection compared with the HS group ( Fig. 2A-C) . The sIgA level was increased in the gastric juice and small intestinal secretions but not in the serum of the HS+SB group by S. boulardii administration after H. suis infection compared with the HS group ( Fig.  2D-F ). These results indicated that feeding with S. boulardii enhanced H. suis-specific humoral immune response locally and systemically by promoting the production of specific IgA in the serum and GI lumen, which might contribute to the decreased colonization of H. suis after S. boulardii administration.
The production of mBD-3 in the small intestinal secretions was significantly increased by Saccharomycesboulardii administration at 12 weeks after Helicobacter suis infection β-Defensins are antimicrobial peptides that exhibit broadspectrum activity against bacteria, viruses and fungi, particularly at the epithelial interface of mucosal surfaces (Abiko et al. 2007) . A murine homolog of human β-defensin-2, also referred to as mBD-3 (Lehrer and Ganz 2002) , is known to be induced in gastric epithelial cells infected by H. pylori and exhibits potent antimicrobial activity against this pathogen (Hamanaka et al. 2001; George et al. 2003) . Here, we revealed that H. suis infection increased the production of mBD-3 in the gastric juice and small intestinal secretions but not in the serum, and this production was enhanced by S. boulardii administration in the HS+SB group at 12 weeks after H. suis infection compared with that in the HS group (Fig. 3A-C ). Moreover, the expression level of mBD-3 mRNA was upregulated in the small intestine but not in the stomach of the HS+SB group at 12 weeks after H. suis infection compared with the HS group ( Fig. 3D and E ). These results showed that feeding with S. boulardii increased mBD-3 production in the small intestine, which may further increase mBD-3 levels in the gastric juice to protect against H. suis infection.
The expression levels of inflammatory cytokines and chemokines in the stomachs were inhibited by Saccharomyces boulardii administration at 12 weeks after Helicobacter suis infection
It has been reported that probiotics suppressed the expression of inflammatory cytokines, such as TNF-α and IL-8, to exert antiinflammatory actions in H. pylori infection by activating SOCS-2 and SOCS-3 expression and signaling (Lee et al. 2010) . Our results also showed that the mRNA expression levels of TNF-α and CXCL15 (human IL-8 homolog) were increased in the stomachs at 12 weeks after H. suis infection and decreased by S. boulardii administration ( Fig. 4A and B) . Moreover, the mRNA expression levels of SOCS-1, 2 and 3 in the stomachs were further upregulated by S. boulardii administration at 12 weeks after H. suis infection (Fig. 4C-E) . In contrast, we previously revealed that B-lymphocyte chemoattractant CXCL13, which may be induced by IFN-γ (Yang et al. 2015) , was crucial for the formation of gastric lymphoid follicles after H. suis infection (Yamamoto et al. 2014) . In addition, chemokine (C-C motif) ligand 2 (CCL2), also referred to as monocyte chemotactic protein 1 (MCP1), was also upregulated in the stomach of H. suis-infected mice (Nobutani et al. 2010) . In this study, the mRNA expression levels of these cytokines and chemokines were increased after H. suis infection and significantly inhibited by S. boulardii administration (Fig. 5A-C) . These data indicated that S. boulardii administration may exert a defense against H. suis infection via antiinflammatory signals through SOCS activation and inhibit the upregulation of lymphoid follicle formation-related factors induced by H. suis infection.
DISCUSSION
The establishment of an animal model for Helicobacter pylori infection has certain limitations. For example, it is difficult for H. pylori to consistently induce lymphoid aggregates in a timely fashion. Gastric carcinogenesis and gastric MALT lymphoma induction takes a long time, and the success rate is low, which hampers the research progress of H. pylori pathogenesis, treatment and vaccine development. In contrast, H. suis is able to colonize well in the stomach of mice and induce the formation of gastric lymphoid follicles or MALT lymphoma more frequently (Nakamura et al. 2007; Yamamoto et al. 2011) . Generally, the formation of gastric MALT lymphoma has two different stages: priming (induced by Helicobacter antigen-dependent inflammation, resulting in MALT formation) and maintenance (usually characterized by chromosome translocation). The lymphoma lesion cannot regress in later stages even though Helicobacter has been eradicated (Zullo et al. 2014) . Therefore, it is important to further investigate the mechanism of gastric MALT development and apply appropriate interventions for preventing the formation of gastric MALT lymphoma.
Helicobacter mainly colonizes the stomach and can be taken up by Peyer's patches (PP) in the small intestine, which plays an essential role in the development of gastritis and anti-Helicobacter antibody production (Kiriya et al. 2007 ). In the GI tract, the epithelial barrier function is a key component of the defense mechanisms that prevent infection and inflammation. The epithelial barrier consists of a dense mucous layer containing sIgA and antimicrobial peptide (e.g. β-defensin), as well as dynamic junctional complexes that regulate permeability between cells (McGuckin et al. 2009 ). In contrast to monomeric serum IgA, mucosal IgA is mainly synthesized as dimeric IgA (dIgA) by plasma cells in the mucosal lamina propria. The units of the dIgA molecule are joined together by a J chain that enables the dIgA to bind at the polyimmunoglobulin receptor. The dIgA-receptor complex is internalized and migrates through the epithelial cell to the luminal surface of the cell, where the polyimmunoglobulin receptor-IgA complex is cleaved and sIgA is released (Macpherson et al. 2007; Cerutti and Rescigno 2008; Brandtzaeg 2010) . Interestingly, PP are not essential for the formation and development of gastric lymphoid follicles induced by H. suis infection, although they are involved in the speed of gastric lymphoid follicle formation (Nobutani et al. 2010) . In H. pyloriinfected mice, most of the IgA in gastric secretion, either antigen specific or non-specific, was derived from swallowed saliva (Shirai et al. 2000) . Therefore, salivary glands may play an important role in the induction and maintenance of gastric immunity to H. suis in mice. Reports claim that Saccharomyces boulardii can promote sIgA secretion into the luminal mucous (Rodrigues et al. 2000; Qamar et al. 2001) , where sIgA protects the intestinal epithelium against colonization and/or invasion by binding antigens on pathogens. Previous report showed that locally produced antibodies, particularly IgA, might block Helicobacter infection by preventing colonization and adhesion. Helicobacterspecific IgA monoclonal antibodies administered directly into the gastric lumen conferred protection against these bacterial infection (Czinn, Cai and Nedrud 1993; Blanchard et al. 1995) . In contrast, potential probiotic strains can also induce the release of β-defensin from epithelial cells into the mucus to prevent the proliferation of pathogens, thus also contributing to barrier integrity (Furrie et al. 2005) . However, the effect of S. boulardii on β-defensin expression in the GI tract remains unclear. The results of this study suggest that S. boulardii administration could inhibit the formation of gastric lymphoid follicles induced by H. suis infection and decrease the bacterial load of H. suis in the stomach and small intestine, which may be due to the increased levels of H. suis-specific IgA, sIgA and mBD-3 in the gastric juice and small intestinal secretions after H. suis infection. These results imply an important effect of S. boulardii in protecting against Helicobacter infection.
In addition to inhibiting pathogenic bacteria, the other mechanism of probiotic treatment in inflammatory-based GI diseases is the suppression of inflammation. Saccharomyces boulardii is reported to be effective in inflammatory GI diseases via multiple mechanisms, including inhibiting the production of proinflammatory cytokines (Pothoulakis 2009 ). The enhancement of SOCS, which is a negative regulator of inflammationassociated cytokine signaling, was found to be a principal mechanism of anti-inflammation (Lee et al. 2010) . Proinflammatory cytokines play multiple roles in the formation of ectopic lymphoid tissues induced by Helicobacter infection. For instance, IL-17 + lymphoid tissue inducer cells are present in the stomach and promote lymphoid follicle formation in response to H. pylori infection (Shiu et al. 2015) . However, lacking IL-17 receptor A signaling promoted B cells recruitment and gastric lymphoid follicles formation elicited by H. pylori infection (Algood et al. 2009 ). The results of this study showed that S. boulardii administration significantly reduced the expression levels of some proinflammatory cytokines in the stomach after H. suis infection, which may be via SOCS activation. In addition, the expression levels of MALT formation-related factors were also suppressed by S. boulardii administration, indicating that these mechanisms were involved in the effect of S. boulardii on the gastric lymphoid follicle formation induced by H. suis infection.
In conclusion, this study revealed that feeding with S. boulardii had an obvious effect on reducing the bacterial load of H. suis and MALT formation in the stomach, demonstrating that this probiotic approach may provide a novel strategy for the prevention and treatment of Helicobacter infection-related diseases.
